In MmD, the symptomatic-only analyses yielded more DEGs than the inclusive analysis; however, confirming ARHGAP36 upregulation and ATN1 and PAIP2 down-regulation, pointing to the active gene regulation needed to control the mitochondrial network and to maintain mitochondrial and cellular health. This evidence concerns the gene ARHGAP36 and multiminicore myopathy.